Apollo Proton Cancer Centre receives prestigious international JCI accreditation
Apollo Proton Cancer Centre receives prestigious international JCI accreditation – India’s 1st dedicated Cancer Center to achieve this distinction
World-Class Apollo Proton Cancer Centre receives prestigious international JCI accreditation – India’s 1st dedicated Cancer Centre to achieve this distinction
Chennai, July 3, 2020: Apollo Proton Cancer Centre (APCC), the first Proton Therapy Centre in South Asia and The Middle East, today announced its accreditation by Joint Commission International (JCI), the recognized glob al leader in health care accreditation. This makes APCC, India’s first dedicated advanced cancer centre to recei ve this international accreditation, and the 8th hospital in the Apollo Hospitals Group to join the portfolio of JCI accredited hospitals. Since its commencement in June 2019, APCC has been the preferred cancer centre across the globe for Proton Therapy and Cancer Care Management. JCI accreditation is a prestigious achievement and benchmark in the healthcare industry for following the best global practices and offering exceptional patient ca re and safety.
Dr. Prathap C Reddy, Chairman, Apollo Hospitals said, “More than 25 years ago, we noted the growing prevalence of cancer in India, the lack of Oncology centres in the country and this was the genesis of Apollo embarking on advanced cancer care. From the very beginning, we brought in the most advanced technologies in cancer care and even the recent launch of South Asia and the Middle East’s first Proton Therapy at Apollo Proton Cancer Centre, reiterates our commitm ent to investing in the best available care for our patients. I am pleased that Apollo Proton Cancer Centre (APCC) has been accorded a special honour, it is now the first advanced cancer centre in India to be accredited by JCI. This recog nition of our quality standards will further strengthen our resolve to keep raising the bar in Oncology!”
“The APCC was conceived to be among the best in the world and in kee ping with this vision; we have the latest state-of-the-art Proton Ther apy machine with the best team of doctors handling various disciplines in Oncology to manage the centre. It is a matter of pride that the top 10 leading Cancer care specialists are working with us and to ensure they can deliver the best of care to our patients, we have equipped them wi th advanced ultramodern medical technology to ens ure our centre is a world class proton care centre!”
The Joint Commission International accreditation is the gold standard given to organizations that practice and follow the highest International Standards in order to provide world-class patient care and safety. A team of exp ert JCI physicians, nurses, and health care administrators evaluated more than a thousand measurable elements and assessed the level of performance in relation to established standards and efforts for continuous improvem ents. This accreditation is proof of the meticulous standards of hospital management and cancer treatment esta blished in the centre, enabling improved and advanced care for patients.
Ms. Preetha Reddy, Vice Chairperson, Apollo Hospitals said, “It was just about 12 months ago, that the very first Proton Therapy in South Asia and The Middle East was unveiled at the Apollo Proton Cancer Centre (APCC) in Chennai. It mark ed a definitive step ahead by making the world’s most advanced radiation therapy much more accessible, benefitting a population of over 3.5 billion people. Now, once again raising the bar, APCC has become the first dedicated cancer hosp ital in India to be accredited by JCI, the gold standard for Quality. It is also the first successful Proton Therapy Centre a ccredited by JCI in South Asia and The Middle East. Further, this milestone was achieved despite the challenges posed by the pandemic, which underscores the APCC’s commitment to quality and advanced patient care.”
The Apollo Proton Cancer Centre introduced Proton Therapy for the first time in India with the expertise of a Multi-Disciplinary Cancer Management Teams and an organ-specific practice. It is also the first and only Proton Ce ntre in South Asia and the Middle East. To date, over 200 pati ents from across the globe have benefitted from Proton Therapy, within its first year of ope ration. The core clinical values of the Oncology team enabled with te chnology makes the treatment successful. A team of well-experienced doctors, management personnel, nurses and care professionals ensure that patients feel safe, comfortable and receive the epitome of oncology care du ring their journey of cancer treatment. The accreditation has motivated the team to push themselves to bring all the efforts together and forge better hea lthcare standards.
“Joint Commission International (JCI) commends Apollo Proton Cancer Centre for its commitment to meeting intern at ional quality and patient safety standards by earning JCI accreditation during the global pandemic,” says Paula Wi lson, president and CEO, JCI. “This achievement was possible by utilizing JCI’s virtual survey process, where surveys are con ducted through the use of technology. This exemplifies how our virtual survey process supports physical distancing and other safety concerns while maintaining the same rigor as a JCI on-site survey.”
The Apollo Proton Cancer Centre aspires to be the best in cancer treatment with a multi-faceted team, prov id ing a top-notch, safe experience for patients. APCC completed the audit and received the accreditation des pite the difficult times of COVID-19 to bring the healthcare of international standards within the reach of every indi vidual. This achievement by the team is a matter of great pride not only to Apollo Group, but also to the nation by being the first advanced cancer hospital in India to be accredited by JCI.
ABOUT APOLLO PROTON CANCER CENTRE
Apollo being one of Asia’s largest healthcare provider has always set the benchmark for patient’s needs and sa fety. The mission is “to bring healthcare of International Standards within the reach of every individual. We are committed to the achievement and maintenance of excellence in education, research and healthcare for the ben efit of humanity.” Apollo Proton Cancer Centre was established in 2019 by Dr Prathap C Reddy, Founder & Cha irman, Apollo Hospitals Group. It is the first advanced cancer centre in India to introduce Proton Therapy, which is considered as the most advanced and targeted cancer treatment due to its superior dose distribution and min imal side effects. The advanced Proton Therapy at APCC is complemented by a fully integrated treatment suite that offers the most advanced treatment procedures in surgical, radiation, and medical oncology. With the holis tic infrastructure and aesthetic environment inbound with positive energy and highly-skilled cancer manag em ent teams, APCC focuses on delivering the best possible clinical outcomes for the patients and is a beacon of ex cellence in Oncology.
